Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03351387
Other study ID # 17-004049
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 20, 2017
Est. completion date April 18, 2018

Study information

Verified date December 2021
Source Mayo Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Researchers are performing this study to evaluate if intraoperative angiography can be shown numerically to determine which wounds are at high risk of wound necrosis/breakdown.


Description:

At the beginning of the Participants surgical procedure, a picture will be obtained using intraoperative angiography using ICG dye which the camera can detect. This dye will be provided through intravenous access. The picture will be taken of the wound to determine preoperative blood flow to the area where the incision is planned. After the wound has been closed postoperatively, a final picture, using the procedure described above, will be taken to determine blood flow after closure of the wound. These images will be obtained using intraoperative angiography. The Participant will be followed after the surgical procedure at standard intervals as determined by the surgeon until the wound heals or requires further intervention.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date April 18, 2018
Est. primary completion date April 18, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: -Surgical indication for high risk lower extremity surgery Exclusion Criteria: - Previous high risk lower extremity surgery - Revision high risk lower extremity surgery - Traumatic amputation - Active infection of any kind or chronic infection with HIV, Hepatitis C, or Syphilis

Study Design


Related Conditions & MeSH terms


Intervention

Combination Product:
SPY Intra-operative Angiography
The SPY Intra-operative Angiography Fluorescent Imaging System consists of an imaging head equipped with a charged coupled device (CCD) camera, a laser light source and a distance sensor. The imaging head is attached to an articulating arm on a mobile cart containing the central processing unit, keyboard, monitor, and mouse. SPY is used in tandem with indocyanine green (ICG), a water-soluble tricarbocyanine dye. Once the camera is in place, 5 cc of diluted ICG is pushed through an IV line and is flushed immediately; simultaneously the room lights must be dimmed. Perfusion images will be recorded then the SPY system will be removed from the operating room.

Locations

Country Name City State
United States Mayo Clinic Rochester Rochester Minnesota

Sponsors (1)

Lead Sponsor Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Wound necrosis Superficial wound necrosis, as evidenced by photography 4 weeks after surgical intervention

External Links